WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H319785
CAS#: 929622-08-2 (free base)
Description: Bavisant, also known as JNJ-31001074, is a highly selective, orally active antagonist of the human H3 receptor with a novel mechanism of action, involving wakefulness and cognition, with potential as a treatment for ADHD. Histamine H3 receptors reside on non-histamine neurons and regulate other neurotransmitters (e.g. acetylcholine, noradrenaline [norepinephrine]) suggesting that H3 antagonists have the potential to improve attention and impulsivity. Research indicates that H3 receptor antagonists due to their novel mechanism of action may have a unique treatment effect offering an important alternative for the treatment of ADHD.
Hodoodo Cat#: H319785
Name: Bavisant
CAS#: 929622-08-2 (free base)
Chemical Formula: C19H27N3O2
Exact Mass: 329.21
Molecular Weight: 329.444
Elemental Analysis: C, 69.27; H, 8.26; N, 12.76; O, 9.71
Related CAS #: 929622-08-2 (free base) 1103522-80-0 (HCl) 929622-09-3 (2HCl anhydrous)
Synonym: JNJ-31001074; JNJ31001074; JNJ 31001074; Bavisant.
IUPAC/Chemical Name: (4-cyclopropylpiperazin-1-yl)(4-(morpholinomethyl)phenyl)methanone
InChi Key: BGBVSGSIXIIREO-UHFFFAOYSA-N
InChi Code: 1S/C19H27N3O2/c23-19(22-9-7-21(8-10-22)18-5-6-18)17-3-1-16(2-4-17)15-20-11-13-24-14-12-20/h1-4,18H,5-15H2
SMILES Code: O=C(N1CCN(C2CC2)CC1)C3=CC=C(CN4CCOCC4)C=C3
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO, not in water
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info: Related: 929622-08-2(Bavisant free base) 1103522-80-0 (Bavisant 2HCl)
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 329.44 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Weisler RH, Pandina GJ, Daly EJ, Cooper K, Gassmann-Mayer C; 31001074-ATT2001
Study Investigators. Randomized clinical study of a histamine H3 receptor
antagonist for the treatment of adults with attention-deficit hyperactivity
disorder. CNS Drugs. 2012 May 1;26(5):421-34. doi:
10.2165/11631990-000000000-00000. PubMed PMID: 22519922.